H-group (homology)
4019.1 alpha-helical domain in beta-lactamase/transpeptidase-like proteins
Ligands and drugs
4,174
Member domains
2,925
with ligand contacts (≤ 4 Å)
70.1% of members
2,621
with DrugDomain annotations
62.8% of members
1,381
with a DrugBank compound
33.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 4019.1 belongs to X-group 4019 alpha-helical domain in beta-lactamase/transpeptidase-like proteins, which binds 8.4 ligand superclasses per 20 proteins, broader than 65% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB08375 | CEF | (2R)-2-[(1R)-1-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-oxoethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid | 44 |
| DB03530 | CAZ | Acylated ceftazidime | 26 |
| DB03834 | TBE | (3S)-3-(dioxidosulfanyl)-N-[(1Z)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine | 22 |
| DB09157 | CO2 | Carbon dioxide | 21 |
| DB04035 | CB4 | Ceftazidime BATSI | 19 |
| DB00142 | GLU | Glutamic acid | 18 |
| DB02145 | 1BO | Butyl alcohol | 13 |
| DB04133 | CED | Degraded Cephaloridine | 13 |
| DB00145 | GLY | Glycine | 12 |
| DB00355 | AZR | Aztreonam | 12 |
| DB08551 | SM2 | 3-{(R)-(Dihydroxyboryl)[(2-thienylacetyl)amino]methyl}benzoic acid | 12 |
| DB12107 | 4D6 | Vaborbactam | 11 |
| DB00513 | ACA | Aminocaproic acid | 10 |
| DB03658 | AXL | (2R,4S)-2-[(1R)-1-{[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid | 10 |
| DB04360 | BZB | Benzo[B]Thiophene-2-Boronic Acid | 10 |
| DB00130 | GLN | L-Glutamine | 9 |
| DB09324 | 0RN | Sulbactam | 9 |
| DB15232 | 63J | Telaglenastat | 8 |
| DB00766 | J01 | Clavulanic acid | 7 |
| DB01896 | APB | M-Aminophenylboronic Acid | 7 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 214 |
| NXL | (2S,5R)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide | 123 |
| NAmetal | SODIUM ION | 71 |
| IM2 | (5R)-5-[(1S,2R)-1-formyl-2-hydroxypropyl]-3-[(2-{[(E)-iminomethyl]amino}ethyl)sulfanyl]-4,5-dihydro-1H-pyrrole-2-carboxylic acid | 45 |
| ZNmetal | ZINC ION | 41 |
| CDmetal | CADMIUM ION | 40 |
| PNM | OPEN FORM - PENICILLIN G | 39 |
| MER | (4R,5S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid | 36 |
| 9F2 | Ceftriaxone | 34 |
| TSL | TRANS-ENAMINE INTERMEDIATE OF SULBACTAM | 34 |
| CEF | CEFOTAXIME, C3' cleaved, open, bound form | 33 |
| CAmetal | CALCIUM ION | 28 |
| CAZ | ACYLATED CEFTAZIDIME | 27 |
| ID1 | Imipenem | 27 |
| IOD | IODIDE ION | 27 |
| Y33 | (5R)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-5-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid | 27 |
| Kmetal | POTASSIUM ION | 25 |
| CO2 | CARBON DIOXIDE | 24 |
| BAmetal | BARIUM ION | 23 |
| TBE | TAZOBACTAM INTERMEDIATE | 22 |